Medicure (MCUJF) Cash from Financing Activities (2011 - 2026)

Medicure's Cash from Financing Activities history runs 14 years deep, the most recent figure standing at -$81671.0 for Q1 2026.

• On a quarterly basis, Cash from Financing Activities fell 31.67% year-over-year to -$81671.0 in Q1 2026; TTM through Mar 2026 was -$316937.9, a 15.12% decrease from a year earlier, with the FY2025 full-year figure at -$297024.4, down 9.91% from the prior year.
• Cash from Financing Activities slipped to -$81671.0 in Q1 2026 per MCUJF's latest filing, from -$79596.6 in the prior quarter.
• Across five years, Cash from Financing Activities topped out at -$52886.6 in Q4 2023 and bottomed at -$167917.4 in Q3 2022.
• The 5-year median for Cash from Financing Activities is -$64085.6 (2022), against an average of -$76192.0.
• Across the five-year window, Cash from Financing Activities plunged 123.45% in 2022 and surged 67.13% in 2023, its largest moves.
• Year by year, Cash from Financing Activities stood at -$167917.4 in 2022, then jumped by 68.5% to -$52886.6 in 2023, then plunged by 62.43% to -$85901.9 in 2024, then climbed by 7.34% to -$79596.6 in 2025, then fell by 2.61% to -$81671.0 in 2026.
• Per Business Quant, the three latest MCUJF Cash from Financing Activities figures stand at -$81671.0 (Q1 2026), -$79596.6 (Q4 2025), and -$74116.8 (Q3 2025).